Heron Therapeutics announces 2025 annual meeting results; all proposals approved

HERON THERAPEUTICS, INC. /DE/

Stockholders elected all six director nominees: Collard, Dissanaike, Johnson, Kaseta, Morgan, Waage, each receiving >79M votes for.
Ratified WithumSmith+Brown as independent auditor for FY2025: 118.6M votes for, 1.0M against.
Approved non-binding advisory vote on 2024 executive compensation: 79.3M for, 3.5M against.
Adopted annual frequency for future say-on-pay advisory votes: 80.5M for 1-year, 2.2M for 3-year.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.